- Cyclerion Therapeutics Inc Clinical Data Update from Study of CY6463 in CIAS Webinar TranscriptJul 28, 2022
- Cyclerion Therapeutics Inc Call to Discuss CY6463 MELAS Clinical Data TranscriptJun 28, 2022
- Cyclerion Therapeutics Inc Pipeline Update Webinar Corporate Call TranscriptApr 27, 2021
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 14, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptJul 09, 2020
- Cyclerion Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 30, 2019
- Cyclerion Therapeutics Inc Investor Webcast Event TranscriptSep 17, 2019
- Cyclerion Therapeutics Inc Corporate Overview Call TranscriptMay 13, 2019
Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, everyone. Good afternoon, and welcome to the 39th Annual JPMorgan Healthcare Conference. My name is Bedir Shather. I'm a Vice President in the Healthcare Investment Banking team here at JPMorgan. We're super excited to be having our next session with Cyclerion. And I'm going to hand it over to our next presenter, Peter Hecht. But before we do that, I just want to make sure that I've reminded everyone that we have a Q&A session at the end of this prepared remarks session, and you should be able to submit questions through the submit a question link, which is a blue bar on the page. And so with that, I'll hand it over to Peter.
Thank you, Bedir. And thank you to not only yourself, but to your whole team. It's been a great week for us. It's been a really terrific opportunity to participate in the conference and to share our excitement for our mission to develop treatments that restore cognitive function. And if you don't mind lingering briefly on Slide 2, you all can control the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)